(lp0
S'STML INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a ... Yahoo Finance - Feb 10, 2017 NEW YORK, March 13, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Stemline Therapeutics, Inc.'
p1
aS'IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action ... Yahoo Finance - Feb 6, 2017 LOS ANGELES, CA / ACCESSWIRE / March 13, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Stemline Therapeutics, Inc.   concerning possible violations of federal&nbsp;...'
p2
aS'Stemline Therapeutics Inc.  Moves Lower on Volume Spike for March 17 Equities.com - 17 hours ago Stemline Therapeutics Inc.  traded on unusually high volume on Mar. 17, as the stock lost 6.4% to close at $9.50. On the day, Stemline Therapeutics Inc. saw 1.16 million shares trade hands on 5,768 trades. Considering that the stock averages only ...Stemline Therapeutics,Inc.  Files An 8-K Results of Operations ... - Market ExclusiveHot Stocks Report: Kopin Corporation , Stemline Therapeutics, Inc.  - Post Analyst'
p3
aS"ALERT: Rosen Law Firm Reminds Stemline Therapeutics, Inc. Investors of ... Yahoo Finance - Mar 13, 2017 NEW YORK, March 13, 2017  -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Stemline Therapeutics, Inc. securities :  pursuant and/or traceable to Stemline's secondary public offering on or about&nbsp;...ALERT: Rosen Law Firm Reminds ReWalk Robotics Ltd. Investors of Important ... - GlobeNewswire "
p4
aS'Why Stemline Therapeutics Inc Stock Is Climbing Today Motley Fool - Jan 6, 2017 The biotech stock rollercoaster known as Stemline Therapeutics Inc  popped Friday morning with a 21.8% gain, and it was still up about 14.5% as of 11:44 a.m.Stemline Therapeutics  Spikes after announcing FDA Agreement - Economic Calendar'
p5
aS'Stemline Investors Reminder: Hagens Berman Reminds Investors in Stemline ... Yahoo Finance - 18 hours ago SAN FRANCISCO, March 17, 2017  -- Hagens Berman Sobol Shapiro LLP reminds investors in Stemline Therapeutics, Inc.  of the April 4, 2017 Lead Plaintiff deadline in the pending securities class action. If you purchased or&nbsp;...'
p6
aS'Stemline Therapeutics Reports Fourth Quarter 2016 Financial Results Nasdaq - Mar 16, 2017 NEW YORK, March 16, 2017  -- Stemline Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology indications of unmet medical need, announced today financial results&nbsp;...'
p7
aS"Here's Why Stemline Therapeutics Stock Fell 36.9% This Morning Motley Fool - Feb 2, 2017 Shares of Stemline Therapeutics  tumbled nearly 37% this morning after investors learned that a patient died in a clinical trial involving its lead drug candidate, SL-401.Side Effect Kills Cancer Patient in Stemline Therapeutics Drug Trial; Company ... - TheStreet.com"
p8
aS"Newman Ferrara LLP Announces Corporate Governance Investigation of Stemline ... Yahoo Finance - Feb 14, 2017 Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Stemline Therapeutics Inc.   into potential breaches of fiduciary duty by the Company's Board of Directors ..."
p9
aS'SHAREHOLDER ALERT: Faruqi &amp; Faruqi, LLP Encourages Investors Who Suffered ... GlobeNewswire  - 19 hours ago NEW YORK, March 17, 2017  -- Faruqi &amp; Faruqi, LLP, a leading national securities law firm, reminds investors in Stemline Therapeutics, Inc.   of the April 4, 2017 deadline to seek the role of&nbsp;...'
p10
a.